By down-regulating glutathione peroxidase 4 (GPX4), the platform synergizes with IFN-γ-induced ferroptotic signaling to intensify tumor-cell lethality, establishing a positive-feedback loop between immune activation and regulated cell death that amplifies antitumor efficacy. The gene discussed is IFNG; the disease is neoplasm.